Dr. Babajide O. Adio, DO

Dr. Adio practices at MercyOne North Iowa Medical Center in Mason City, Iowa, part of Trinity Health.

Dr. Adio's NPI, 1962934844, was assigned on March 30, 2017. Dr. Adio holds Wisconsin license 81165.

Dr. Adio's primary practice is MercyOne North Iowa Medical Center, at 1000 Fourth Street SW, Mason City, IA 50401 in Cerro Gordo County. The practice phone is (641) 428-7000.

Dr. Adio's primary practice is MercyOne North Iowa Medical Center in Mason City, Iowa, part of Trinity Health. Dr. Adio is also affiliated with Froedtert Hospital. The medical group on file is MercyOne North Iowa Anesthesia Professional Services. Dmand AI also links Dr. Adio to 1 more hospital, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adio practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Adio's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Adio's licenses on file in 2 states: Wisconsin and Iowa.

CMS data shows 289 Medicare services from Dr. Adio across 4 procedure codes in 2024, for 108 Medicare patients. Medicare paid $18,366 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 108 Medicare patients who saw Dr. Adio in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adio's median patient age at 67, with 52% women.

In 2024, Dr. Adio wrote 181 Medicare Part D claims for 69 patients. 86% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $28 in total drug cost. In 2022, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Adio for performance year 2024, reported as part of a group. Dr. Adio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Adio, published from 2020 to 2025. 2022 was the busiest year, with 2. Dr. Adio has published most often in Cureus. Dr. Adio's most frequent co-authors are Elias Smirlis, MD, Christian M. De Souza, DO and Alireza Yarahmadi, MD.

CMS Open Payments shows 3 general payments to Dr. Adio from 2 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $151.